We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.
The stock's rise snapped a four-day losing streak.
Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results